Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunogenicity and Safety of Multiple Formulations of an Adjuvanted A/H1N1 Pandemic Vaccine in Healthy Adult and Elderly Subjects

NCT00952276 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT00952276
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00952276 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunogenicity and Safety of Multiple Formulations of an Adjuvanted A/H1N1 Pandemic Vaccine in Healthy Adult and Elderly Subjects
Lead sponsor
Sanofi
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2009
Completion date
March 31, 2011
Enrollment
548 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

influenza, swine-origin a/h1n1 influenza